z-logo
Premium
An adenosine A 2A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats
Author(s) -
Hong ZongYuan,
Huang ZhiLi,
Qu WeiMin,
Eguchi Naomi,
Urade Yoshihiro,
Hayaishi Osamu
Publication year - 2005
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2004.02991.x
Subject(s) - histaminergic , agonist , chemistry , basal forebrain , histamine , microdialysis , neuroscience , medicine , endocrinology , pharmacology , biology , receptor , extracellular , central nervous system , biochemistry
The adenosine A 2A receptor (A 2A R) has been demonstrated to play a crucial role in the regulation of the sleep process. However, the molecular mechanism of the A 2A R‐mediated sleep remains to be elucidated. Here we used electroencephalogram and electromyogram recordings coupled with in vivo microdialysis to investigate the effects of an A 2A R agonist, CGS21680, on sleep and on the release of histamine and GABA in the brain. In freely moving rats, CGS21680 applied to the subarachnoid space underlying the rostral basal forebrain significantly promoted sleep and inhibited histamine release in the frontal cortex. The histamine release was negatively correlated with the amount of non‐rapid eye movement sleep ( r =  − 0.652). In urethane‐anesthetized rats, CGS21680 inhibited histamine release in both the frontal cortex and medial pre‐optic area in a dose‐dependent manner, and increased GABA release specifically in the histaminergic tuberomammillary nucleus but not in the frontal cortex. Moreover, the CGS21680‐induced inhibition of histamine release was antagonized by perfusion of the tuberomammillary nucleus with a GABA A antagonist, picrotoxin. These results suggest that the A 2A R agonist induced sleep by inhibiting the histaminergic system through increasing GABA release in the tuberomammillary nucleus.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here